CHLOROPHYLLIPT® ARTERIUM

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT CHLOROPHYLLIPT® Arterium (CHLOROPHYLLIPT Arterium)

Composition:

Active substance: 1 ml of solution contains 20 mg of thick extract of eucalyptus leaves (extractum ex folii eucalypti spissum) (1:15.3) (extractant – 96% ethanol, v/v);

Excipient: sunflower oil.

Pharmaceutical form. Oil solution.

Main physicochemical properties: transparent oily liquid of dark green color. Formation of sediment during storage is permissible.

Pharmacotherapeutic group. Antiseptics and disinfectants. ATC code D08AX.

Pharmacological properties.

Chlorophyllipt® Arterium is a mixture of chlorophylls from eucalyptus leaves. The drug has antibacterial (bacteriostatic and bactericidal) activity against staphylococci, as well as antiseptic and anti-inflammatory activity.

Clinical characteristics.

Indications.

Treatment of diseases caused by antibiotic-resistant staphylococci: cervical erosion, burns, trophic ulcers.

Contraindications.

Hypersensitivity to any component of the drug.

Interaction with other medicinal products and other forms of interactions.

Enhances the effect of antiseptic agents.

Instructions for use.

Consult a physician before starting use.

After the first application, a pause of 6–8 hours should be made. Course treatment with the drug is possible only after confirming the absence of an allergic reaction to the dense chlorophyllipt extract (risk of swelling of the lips, nasal mucosa, pharynx, and other allergic reactions). If any of the above symptoms occur, discontinue use of the drug and consult a physician.

Use during pregnancy or breastfeeding.
The efficacy and safety of the drug during pregnancy or breastfeeding have not been studied; therefore, the drug should not be used in these patient groups.

Ability to affect reaction rate while driving or operating machinery. Does not affect.

Method of Administration and Dosage

Before use, the preparation must be shaken.

The preparation is intended for topical application, applied to affected areas using a swab. The duration of applications and treatment course is determined individually by the physician.

For treatment of cervical erosion, previously dry all vaginal folds and the vaginal portion of the cervix with swabs; apply Chlorophyllipt® Arterium to the cervical canal. Leave a swab moistened with the preparation on the cervix for 15–20 minutes. Perform the procedure once daily for 10 days. If erosion epithelialization is incomplete, the treatment course should be repeated (after consultation with a physician).

Children. Experience with use of the preparation in children is lacking.

Overdose. May result in increased intensity of adverse reactions. Treatment is symptomatic.

Side effects.

Immune system side effects: allergic reactions may occur during use of the drug, including mucosal swelling, hyperemia at the application site, itching, rash.

Shelf life. 3 years.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C, in a place inaccessible to children.

Packaging.

25 ml or 30 ml in a bottle, 1 bottle per carton.

Availability.

Over-the-counter.

Manufacturer.

JSC "Halychpharm".

Manufacturer's address.

6/8 Opryshkivska Street, Lviv, 79024, Ukraine.